Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients

Similar documents
Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection

Intravitreal Injection

Treatment of Retinal Vein Occlusion (RVO)

Treatment of Diabetic Macular Oedema by Intravitreal Injection with Ranibizumab (Lucentis)

RETINAL CONDITIONS RETINAL CONDITIONS

GENERAL INFORMATION DIABETIC EYE DISEASE

Introduction How the eye works

Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent

Information for patients

In all cases, a doctor will explain the procedure to you and answer any questions you may have.

What is Age-Related Macular Degeneration?

INFORMED CONSENT FOR AVASTIN TM (BEVACIZUMAB) INTRAVITREAL INJECTION

Patient Information Argon macular laser treatment Introduction

Ophthalmology. Ophthalmology Services

EYLEA. (aflibercept solution for injection) Patient Guide

Epiretinal membrane. Information for patients Ophthalmology (Vitreal Retina) Large Print

Photodynamic Therapy (PDT) for agerelated

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection

Brampton Hurontario Street Brampton, ON L6Y 0P6

Epiretinal membrane. What is an epiretinal membrane?

Important: Please read before your appointment

Diabetic Eye Disease

Information for Patients. Vitrectomy

Patient information Eylea treatment for diabetic macular oedema (DMO)

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

Patient information. Retinal Detachment Surgery St. Paul s Eye Unit PIF 024 V7

Preparing for laser treatment for diabetic retinopathy and maculopathy

Cataract Surgery. Patient Information. How your care will be organised. Introduction

Information for patients. Epiretinal Membrane. Royal Hallamshire Hospital

If you would like further information, please ask any of the staff at the clinic. They will be happy to help.

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

Age-related Macular Degeneration (AMD) treatment information

GHPI0100_06_10 Contact: Ophthalmology Review due: June What is a Cataract?

Patient Information Cataract Surgery

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

UVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Age-Related Macular Degeneration (AMD)

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Age-Related. macular degeneration.

Cataract Surgery Patient Information

PATIENT INFORMATION LEAFLET MACULAR HOLE. What is the macula?

A Patient s Guide to Diabetic Retinopathy

Diabetes & Your Eyes

Diabetic Retinopathy Information

VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz)

Macular holes. What is a macular hole?

OP01 Cataract Surgery (Phacoemulsification)

Understanding. Eye conditions related to diabetes

Information for Patients. Macular Hole

The cataract laser technology of tomorrow is here for you today. See inside to learn about all your exciting new options

Intravitreal Injections for Wet Age Related Macular Degeneration

eye conditions related to diabetes

Macular Hole Surgery

Understanding. Cataracts

OAKLEIGH EYE CENTRE. THE EYE Before looking at diabetic retinopathy it is important to understand what the healthy eye looks like and how it works.

Frequently Asked Questions about General Ophthalmology:

Patient Information: Macular Hole Surgery

Information for Patients. Retinal Detachment

Retinal Detachment. Patient Information Leaflet. Ophthalmic Day Surgical Unit

Macular hole. Information for patients Ophthalmology (Vitreal Retina) Large Print

Asymptomatic retinal detachment

Facts About Diabetic Eye Disease

Diabetic Retinopathy

Scrub In. What is the function of vitreous humor? What does the pupil do when exposed to bright light? a. Maintain eye shape and provide color vision

UNDERSTAND MORE ABOUT UVEITIS UVEITIS

The risks and benefits of cataract surgery

Vitrectomy for diabetic vitreous haemorrhage

Rapid Visual Loss. Dr Michael Johnson PhD FCOptom DipOrth DipGlauc DipTp(IP) Independent Prescribing Optometrist

Cataracts (1 of 7) What is a cataract? What can be done about a cataract? Lens

Cataract. What is a Cataract?

X-Plain Diabetic Retinopathy Reference Summary

Myopia and pathological myopia. Fundus Photo, Right Eye (OD)

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Cataracts in babies and children

What you can expect with OZURDEX

Macular Hole. Helpline

Cataract. What is a Cataract?

Cataract Surgery: Information for patients. Back of eye. Vitreous. Retina. Lens

Diabetic Retinopathy A Presentation for the Public

Retinal Tears and Detachments

Here s what you need to know about your treatment with JETREA (ocriplasmin)

DIABETIC RETINOPATHY

Screening saves sight. The importance of regular testing for diabetic retinopathy

Having a vitrectomy surgery to repair your retinal detachment

Retinopathy Of Prematurity (or) Retrolental Fibroplasia )

GENERAL INFORMATION CORNEAL TRANSPLANTATION

Cataract = opaque lens

About your graft for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Epiretinal Membrane (Scar Tissue)

RVO RETINAL VEIN OCCLUSION

Diabetic Retinopathy Screening Programme

Year 2 MBChB Clinical Skills Session Ophthalmoscopy. Reviewed & ratified by: Mr M Batterbury Consultant Ophthalmologist

Patient information. Intraocular Tumour Biopsy St. Paul s Eye Unit PIF1201 V1

Understanding Cataracts

Eye screening for patients taking hydroxychloroquine (Plaquenil )

Vitrectomy for diabetic vitreous haemorrhage

About your fistula for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Diabetic Retinopathy. What should know

Transcription:

Ophthamology Directorate Eye Injection for Macular Disorders Information for Patients As discussed at your appointment today, please call the Medical Retinal Services Coordinator as soon as possible (within 48 hours) to arrange your treatment plan. Treatment can be offered at Norwich or Cromer Hospitals or the Central Norwich Eye Clinic. Medical Retinal Coordinator: 01603 288311 Monday to Friday 08.30 16.30 hours Introduction You have recently been diagnosed with a macular disorder. Wet macular degeneration Branch retinal vein occlusion Central retinal vein occlusion Diabetic macular oedema Pathological myopia If left untreated, there is a high chance of your central vision becoming more blurred or distorted. What does this mean? The macula is the central part of the retina used for fine detail vision e.g. reading and recognising faces. 1. Wet macular degeneration is caused by leakage from blood vessels which grow under the retina, causing swelling and bleeding in the retina. This leads to scar formation and damage to the overlying retina, with loss of central vision.

2. Retinal vein occlusion (branch/central) is caused by a blockage in the vein within the eye. 3. Macular oedema is swelling in the centre of the retina due to fluid leaking from damaged retinal blood vessels. This damage is commonly due to diabetes or blockage (occlusion). This leads to blurring of the central vision. 4. Pathological myopia is where you are shown to be very short sighted with degenerative changes at the back of the eye. Treatment is available and involves the injection of a drug into the eye to prevent the degenerative blood vessels from growing and leaking. This treatment blocks the action of a growth factor (Vascular Endothelial Growth Factor - VEGF). The drugs available are called anti VEGF which contain a fragment of an antibody against VEGF and it improves vision in around 30 40% of patients. In 40% of patients, vision stays the same. In 30% of patients vision can still deteriorate despite treatment. Treatment Plan The initial phase includes 3 injections at monthly intervals, with a review in the clinic three weeks after the third injection. Subsequently repeat injections are given when there are signs of recurrent disease activity further blurring of vision, or leak detected in the macula when you are reviewed in the clinic.

After the initial three treatments, most people need repeat treatments, often at 2 or 3 monthly intervals. On average patients need 7-8 injections in the first year, 4 in second year and 2-3 in the third year. You would normally be seen in the review clinic for a checkup at 4 to 6 weekly intervals. At this visit you will have your pupils dilated. A retinal scan will be performed and the doctor will tell you if you need a further injection. If you have suffered a heart attack or a stroke in the three months prior to your injection, please inform Doctor or nursing staff in the clinic. The Procedure Treatment is carried out as an outpatient. There will be a nurse to look after you. Please DO NOT DRIVE yourself to this appointment. Please do not w ear an y e ye makeup on the da y of treatment. Drops are put in to numb your eye. A drop of iodine cleans the surface of your eye. Your eyelids are held open by a springy clip and 0.05ml of the drug is injected through the white of your eye using a tiny thin needle. The injected eye may be covered with a shield for two hours. You will experience some blurring of your vision at first and people often notice a greasy smear or floaters in the vision at first, which is the drug. This usually wears off within 48 hours. Complications

The risk to your eye from the injection is very small. On average complications (problems) occur only once in every 1000 injections, and include: 1. A serious infection inside the eye (endophthalmitis), which can blind the eye. In this hospital this occurs approximately once in every 4,000 injections. 2. Damage to the retina causing a retinal detachment 3. Damage to the lens causing a cataract 4. Haemorrhage in the jelly of the eye (vitreous) 5. Blockage of retinal circulation with damage to the optic nerve. 6. Persistent floaters 7. Increased distortion 8. Corneal abrasion (scratch on the front surface of the eye). Rarely this can occur at the time of the injection. If this happens you will be advised about painkillers to use along with your eye-drops. The injection may cause a small haemorrhage (bruise) on the surface of the white of your eye, which will clear in a week or two. Your eye may feel a little sore for a couple of hours after the injection. Surface irritation can make the eye water for 24-48 hours and may require painkillers. What to do if yo u have problems after the injection Phone for advice if you have: Increasing blurring, pain and red eye, which may be signs of infection.

Dark floaters or flashing bright light in your eye which occur newly after the treatment possibly due to retinal detachment or haemorrhage. If you have any questions or worries, please contact: Eye Clinic - 016 03 288066 Monday - Thursday 08.45-17.30 hours Friday 08.45-15.00 hours Central Norwich Eye Clinic - 016 03 647101 At all other times please ring 01603 28628 6 and ask the switchboard to contact the Ophthalmic (Eye) Doctor on call. Here are some contact telephone numbers for support agencies: Norfolk and Norwich Association for the Blind: 01603 629558 Norfolk County Council Social Services Sensory Support Unit: 01603 729221 Norwich Social Centre for the Blind: 01603 621937 RNIB Helpline: 0303 123 9999